Global Cerebral Balloon Angioplasty & Stenting Systems

Cerebral Balloon Angioplasty & Stenting Systems Comprehensive Study by Type (Carotid Artery Stents, Embolic Protection Systems), Application (Hospitals, Clinics, Ambulatory Surgical Units) Players and Region - Global Market Outlook to 2024

Cerebral Balloon Angioplasty & Stenting Systems Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Vascular structure of the nervous tissue and blood vessels are majorly affected in the patient with neurovascular disorder. This leads in moderate to severe damage to the brain resulting in the condition such as cerebral haemorrhage and strokes. A Cerebral Balloon Angioplasty & Stenting Systems is a device used to open partially blocked vertebral and carotid arteries in the neck as well as blood vessels within the brain. Rising geriatric population across is expected to increase the demand for the country and upsurge in the number of patient suffering from brain disease Cerebral Balloon Angioplasty & Stenting Systems. As per WHO, the global geriatric population (aged 65 years and above) is expected to rise from 7% in 2000 to 16% in 2050.This growth is primarily driven by Large Obese and Ageing Population, Favorable Medical Reimbursement and Expansion of Healthcare Infrastructure across Emerging Market.

Globally, a noticeable market trend is evident Advancement In The Manufacturing Process of Cerebral Balloon Angioplasty & Stenting Systems. Major Players, such as Medtronic, Plc (United States), W.L. Gore & Associates, Johnson & Johnson (United States), Stryker Corporation (United States), Abbott Vascular (United States), Terumo Corporation (Japan), Microport Scientific Corporation (China) and Penumbra (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Large Obese and Ageing Population
  • Favorable Medical Reimbursement
  • Expansion of Healthcare Infrastructure across Emerging Market

Market Trend
  • Advancement In The Manufacturing Process of Cerebral Balloon Angioplasty & Stenting Systems

Restraints
  • Stringent Government Rules and Regulation
  • High Cost Associated with Cerebral Balloon Angioplasty & Stenting Systems

Opportunities
Potential Growth in Emerging Market
Challenges
Lack of Skilled Professionals

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Carotid Artery Stents
  • Embolic Protection Systems
By Application
  • Hospitals
  • Clinics
  • Ambulatory Surgical Units
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Large Obese and Ageing Population
      • 3.2.2. Favorable Medical Reimbursement
      • 3.2.3. Expansion of Healthcare Infrastructure across Emerging Market
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Advancement In The Manufacturing Process of Cerebral Balloon Angioplasty & Stenting Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cerebral Balloon Angioplasty & Stenting Systems, by Type, Application and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Cerebral Balloon Angioplasty & Stenting Systems (Value)
      • 5.2.1. Global Cerebral Balloon Angioplasty & Stenting Systems by: Type (Value)
        • 5.2.1.1. Carotid Artery Stents
        • 5.2.1.2. Embolic Protection Systems
      • 5.2.2. Global Cerebral Balloon Angioplasty & Stenting Systems by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Ambulatory Surgical Units
      • 5.2.3. Global Cerebral Balloon Angioplasty & Stenting Systems Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Cerebral Balloon Angioplasty & Stenting Systems (Volume)
      • 5.3.1. Global Cerebral Balloon Angioplasty & Stenting Systems by: Type (Volume)
        • 5.3.1.1. Carotid Artery Stents
        • 5.3.1.2. Embolic Protection Systems
      • 5.3.2. Global Cerebral Balloon Angioplasty & Stenting Systems by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Ambulatory Surgical Units
      • 5.3.3. Global Cerebral Balloon Angioplasty & Stenting Systems Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Cerebral Balloon Angioplasty & Stenting Systems (Price)
      • 5.4.1. Global Cerebral Balloon Angioplasty & Stenting Systems by: Type (Price)
  • 6. Cerebral Balloon Angioplasty & Stenting Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic, Plc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. W.L. Gore & Associates
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Stryker Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abbott Vascular (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Terumo Corporation (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Microport Scientific Corporation (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Penumbra (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Cerebral Balloon Angioplasty & Stenting Systems Sale, by Type, Application and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Cerebral Balloon Angioplasty & Stenting Systems (Value)
      • 7.2.1. Global Cerebral Balloon Angioplasty & Stenting Systems by: Type (Value)
        • 7.2.1.1. Carotid Artery Stents
        • 7.2.1.2. Embolic Protection Systems
      • 7.2.2. Global Cerebral Balloon Angioplasty & Stenting Systems by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Ambulatory Surgical Units
      • 7.2.3. Global Cerebral Balloon Angioplasty & Stenting Systems Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Cerebral Balloon Angioplasty & Stenting Systems (Volume)
      • 7.3.1. Global Cerebral Balloon Angioplasty & Stenting Systems by: Type (Volume)
        • 7.3.1.1. Carotid Artery Stents
        • 7.3.1.2. Embolic Protection Systems
      • 7.3.2. Global Cerebral Balloon Angioplasty & Stenting Systems by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Ambulatory Surgical Units
      • 7.3.3. Global Cerebral Balloon Angioplasty & Stenting Systems Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Cerebral Balloon Angioplasty & Stenting Systems (Price)
      • 7.4.1. Global Cerebral Balloon Angioplasty & Stenting Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cerebral Balloon Angioplasty & Stenting Systems: by Type(USD Million)
  • Table 2. Cerebral Balloon Angioplasty & Stenting Systems Carotid Artery Stents , by Region USD Million (2013-2018)
  • Table 3. Cerebral Balloon Angioplasty & Stenting Systems Embolic Protection Systems , by Region USD Million (2013-2018)
  • Table 4. Cerebral Balloon Angioplasty & Stenting Systems: by Application(USD Million)
  • Table 5. Cerebral Balloon Angioplasty & Stenting Systems Hospitals , by Region USD Million (2013-2018)
  • Table 6. Cerebral Balloon Angioplasty & Stenting Systems Clinics , by Region USD Million (2013-2018)
  • Table 7. Cerebral Balloon Angioplasty & Stenting Systems Ambulatory Surgical Units , by Region USD Million (2013-2018)
  • Table 8. South America Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2013-2018)
  • Table 9. South America Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 10. South America Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 11. Brazil Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 12. Brazil Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 13. Argentina Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 14. Argentina Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 15. Rest of South America Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 16. Rest of South America Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 17. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2013-2018)
  • Table 18. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 19. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 20. China Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 21. China Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 22. Japan Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 23. Japan Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 24. India Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 25. India Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 26. South Korea Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 27. South Korea Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 28. Taiwan Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 29. Taiwan Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 30. Australia Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 31. Australia Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 32. Rest of Asia-Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 34. Europe Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2013-2018)
  • Table 35. Europe Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 36. Europe Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 37. Germany Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 38. Germany Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 39. France Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 40. France Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 41. Italy Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 42. Italy Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 43. United Kingdom Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 44. United Kingdom Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 45. Netherlands Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 46. Netherlands Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 47. Rest of Europe Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 48. Rest of Europe Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 49. MEA Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2013-2018)
  • Table 50. MEA Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 51. MEA Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 52. Middle East Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 53. Middle East Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 54. Africa Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 55. Africa Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 56. North America Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2013-2018)
  • Table 57. North America Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 58. North America Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 59. United States Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 60. United States Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 61. Canada Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 62. Canada Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 63. Mexico Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2013-2018)
  • Table 64. Mexico Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2013-2018)
  • Table 65. Cerebral Balloon Angioplasty & Stenting Systems Sales: by Type(Units)
  • Table 66. Cerebral Balloon Angioplasty & Stenting Systems Sales Carotid Artery Stents , by Region Units (2013-2018)
  • Table 67. Cerebral Balloon Angioplasty & Stenting Systems Sales Embolic Protection Systems , by Region Units (2013-2018)
  • Table 68. Cerebral Balloon Angioplasty & Stenting Systems Sales: by Application(Units)
  • Table 69. Cerebral Balloon Angioplasty & Stenting Systems Sales Hospitals , by Region Units (2013-2018)
  • Table 70. Cerebral Balloon Angioplasty & Stenting Systems Sales Clinics , by Region Units (2013-2018)
  • Table 71. Cerebral Balloon Angioplasty & Stenting Systems Sales Ambulatory Surgical Units , by Region Units (2013-2018)
  • Table 72. South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2013-2018)
  • Table 73. South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 74. South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 75. Brazil Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 76. Brazil Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 77. Argentina Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 78. Argentina Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 79. Rest of South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 80. Rest of South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 81. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2013-2018)
  • Table 82. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 83. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 84. China Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 85. China Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 86. Japan Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 87. Japan Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 88. India Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 89. India Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 90. South Korea Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 91. South Korea Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 92. Taiwan Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 93. Taiwan Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 94. Australia Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 95. Australia Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 96. Rest of Asia-Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 97. Rest of Asia-Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 98. Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2013-2018)
  • Table 99. Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 100. Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 101. Germany Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 102. Germany Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 103. France Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 104. France Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 105. Italy Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 106. Italy Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 107. United Kingdom Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 108. United Kingdom Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 109. Netherlands Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 110. Netherlands Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 111. Rest of Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 112. Rest of Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 113. MEA Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2013-2018)
  • Table 114. MEA Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 115. MEA Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 116. Middle East Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 117. Middle East Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 118. Africa Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 119. Africa Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 120. North America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2013-2018)
  • Table 121. North America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 122. North America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 123. United States Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 124. United States Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 125. Canada Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 126. Canada Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 127. Mexico Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2013-2018)
  • Table 128. Mexico Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2013-2018)
  • Table 129. Cerebral Balloon Angioplasty & Stenting Systems: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Cerebral Balloon Angioplasty & Stenting Systems: by Type(USD Million)
  • Table 139. Cerebral Balloon Angioplasty & Stenting Systems Carotid Artery Stents , by Region USD Million (2019-2024)
  • Table 140. Cerebral Balloon Angioplasty & Stenting Systems Embolic Protection Systems , by Region USD Million (2019-2024)
  • Table 141. Cerebral Balloon Angioplasty & Stenting Systems: by Application(USD Million)
  • Table 142. Cerebral Balloon Angioplasty & Stenting Systems Hospitals , by Region USD Million (2019-2024)
  • Table 143. Cerebral Balloon Angioplasty & Stenting Systems Clinics , by Region USD Million (2019-2024)
  • Table 144. Cerebral Balloon Angioplasty & Stenting Systems Ambulatory Surgical Units , by Region USD Million (2019-2024)
  • Table 145. South America Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2019-2024)
  • Table 146. South America Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 147. South America Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 148. Brazil Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 149. Brazil Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 150. Argentina Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 151. Argentina Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 152. Rest of South America Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 153. Rest of South America Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 154. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2019-2024)
  • Table 155. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 156. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 157. China Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 158. China Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 159. Japan Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 160. Japan Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 161. India Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 162. India Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 163. South Korea Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 164. South Korea Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 165. Taiwan Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 166. Taiwan Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 167. Australia Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 168. Australia Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 169. Rest of Asia-Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 170. Rest of Asia-Pacific Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 171. Europe Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2019-2024)
  • Table 172. Europe Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 173. Europe Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 174. Germany Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 175. Germany Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 176. France Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 177. France Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 178. Italy Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 179. Italy Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 180. United Kingdom Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 181. United Kingdom Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 182. Netherlands Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 183. Netherlands Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 184. Rest of Europe Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 185. Rest of Europe Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 186. MEA Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2019-2024)
  • Table 187. MEA Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 188. MEA Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 189. Middle East Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 190. Middle East Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 191. Africa Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 192. Africa Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 193. North America Cerebral Balloon Angioplasty & Stenting Systems, by Country USD Million (2019-2024)
  • Table 194. North America Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 195. North America Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 196. United States Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 197. United States Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 198. Canada Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 199. Canada Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 200. Mexico Cerebral Balloon Angioplasty & Stenting Systems, by Type USD Million (2019-2024)
  • Table 201. Mexico Cerebral Balloon Angioplasty & Stenting Systems, by Application USD Million (2019-2024)
  • Table 202. Cerebral Balloon Angioplasty & Stenting Systems Sales: by Type(Units)
  • Table 203. Cerebral Balloon Angioplasty & Stenting Systems Sales Carotid Artery Stents , by Region Units (2019-2024)
  • Table 204. Cerebral Balloon Angioplasty & Stenting Systems Sales Embolic Protection Systems , by Region Units (2019-2024)
  • Table 205. Cerebral Balloon Angioplasty & Stenting Systems Sales: by Application(Units)
  • Table 206. Cerebral Balloon Angioplasty & Stenting Systems Sales Hospitals , by Region Units (2019-2024)
  • Table 207. Cerebral Balloon Angioplasty & Stenting Systems Sales Clinics , by Region Units (2019-2024)
  • Table 208. Cerebral Balloon Angioplasty & Stenting Systems Sales Ambulatory Surgical Units , by Region Units (2019-2024)
  • Table 209. South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2019-2024)
  • Table 210. South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 211. South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 212. Brazil Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 213. Brazil Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 214. Argentina Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 215. Argentina Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 216. Rest of South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 217. Rest of South America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 218. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2019-2024)
  • Table 219. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 220. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 221. China Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 222. China Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 223. Japan Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 224. Japan Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 225. India Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 226. India Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 227. South Korea Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 228. South Korea Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 229. Taiwan Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 230. Taiwan Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 231. Australia Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 232. Australia Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 233. Rest of Asia-Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 234. Rest of Asia-Pacific Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 235. Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2019-2024)
  • Table 236. Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 237. Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 238. Germany Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 239. Germany Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 240. France Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 241. France Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 242. Italy Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 243. Italy Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 244. United Kingdom Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 245. United Kingdom Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 246. Netherlands Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 247. Netherlands Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 248. Rest of Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 249. Rest of Europe Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 250. MEA Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2019-2024)
  • Table 251. MEA Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 252. MEA Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 253. Middle East Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 254. Middle East Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 255. Africa Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 256. Africa Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 257. North America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Country Units (2019-2024)
  • Table 258. North America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 259. North America Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 260. United States Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 261. United States Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 262. Canada Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 263. Canada Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 264. Mexico Cerebral Balloon Angioplasty & Stenting Systems Sales, by Type Units (2019-2024)
  • Table 265. Mexico Cerebral Balloon Angioplasty & Stenting Systems Sales, by Application Units (2019-2024)
  • Table 266. Cerebral Balloon Angioplasty & Stenting Systems: by Type(USD/Units)
  • Table 267. Research Programs/Design for This Report
  • Table 268. Key Data Information from Secondary Sources
  • Table 269. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cerebral Balloon Angioplasty & Stenting Systems: by Type USD Million (2013-2018)
  • Figure 5. Global Cerebral Balloon Angioplasty & Stenting Systems: by Application USD Million (2013-2018)
  • Figure 6. South America Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 7. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 8. Europe Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 9. MEA Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 10. North America Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 11. Global Cerebral Balloon Angioplasty & Stenting Systems: by Type Units (2013-2018)
  • Figure 12. Global Cerebral Balloon Angioplasty & Stenting Systems: by Application Units (2013-2018)
  • Figure 13. South America Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 14. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 15. Europe Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 16. MEA Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 17. North America Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 18. Global Cerebral Balloon Angioplasty & Stenting Systems: by Type USD/Units (2013-2018)
  • Figure 19. Global Cerebral Balloon Angioplasty & Stenting Systems share by Players 2018 (%)
  • Figure 20. Global Cerebral Balloon Angioplasty & Stenting Systems share by Players (Top 3) 2018(%)
  • Figure 21. Global Cerebral Balloon Angioplasty & Stenting Systems share by Players (Top 5) 2018(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Medtronic, Plc (United States) Revenue, Net Income and Gross profit
  • Figure 24. Medtronic, Plc (United States) Revenue: by Geography 2018
  • Figure 25. W.L. Gore & Associates Revenue, Net Income and Gross profit
  • Figure 26. W.L. Gore & Associates Revenue: by Geography 2018
  • Figure 27. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 28. Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 29. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Stryker Corporation (United States) Revenue: by Geography 2018
  • Figure 31. Abbott Vascular (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott Vascular (United States) Revenue: by Geography 2018
  • Figure 33. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Terumo Corporation (Japan) Revenue: by Geography 2018
  • Figure 35. Microport Scientific Corporation (China) Revenue, Net Income and Gross profit
  • Figure 36. Microport Scientific Corporation (China) Revenue: by Geography 2018
  • Figure 37. Penumbra (United States) Revenue, Net Income and Gross profit
  • Figure 38. Penumbra (United States) Revenue: by Geography 2018
  • Figure 39. Global Cerebral Balloon Angioplasty & Stenting Systems: by Type USD Million (2019-2024)
  • Figure 40. Global Cerebral Balloon Angioplasty & Stenting Systems: by Application USD Million (2019-2024)
  • Figure 41. South America Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 42. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 43. Europe Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 44. MEA Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 45. North America Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 46. Global Cerebral Balloon Angioplasty & Stenting Systems: by Type Units (2019-2024)
  • Figure 47. Global Cerebral Balloon Angioplasty & Stenting Systems: by Application Units (2019-2024)
  • Figure 48. South America Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 49. Asia Pacific Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 50. Europe Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 51. MEA Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 52. North America Cerebral Balloon Angioplasty & Stenting Systems Share (%), by Country
  • Figure 53. Global Cerebral Balloon Angioplasty & Stenting Systems: by Type USD/Units (2019-2024)
List of companies from research coverage that are profiled in the study
  • Medtronic, Plc (United States)
  • W.L. Gore & Associates
  • Johnson & Johnson (United States)
  • Stryker Corporation (United States)
  • Abbott Vascular (United States)
  • Terumo Corporation (Japan)
  • Microport Scientific Corporation (China)
  • Penumbra (United States)
Select User Access Type

Key Highlights of Report


Jun 2019 242 Pages 61 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cerebral Balloon Angioplasty & Stenting Systems Quantitative research analysis
Global Cerebral Balloon Angioplasty & Stenting Systems Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Cerebral Balloon Angioplasty & Stenting Systems Report?

Have a Query? Click Here

Other Related Reports

Radiosurgical System Comprehensive Study by Type (Gamma Knife, Linear Accelerator, Proton Beam, Others), Application (Brain Tumors, Arteriovenous Malformations (AVMs), Trigeminal Neuralgia, Tremor, O...
$ 3450
Wireless Hearing Aid Comprehensive Study by Type (Receiver-In-The-Ear, Behind-The-Ear, In-The-Ear, Bone Anchored Systems), Application (Adults, Children) Players and Region - Global Market Outlook to...
$ 3500
Cardiac Arrhythmia Monitoring Devices Comprehensive Study by Type (Implantable Cardiac Monitors, Resting ECG Devices, ECG Stress Test Devices, Mobile Cardiac Telemetry Monitors, Holter Monitors), App...
$ 3750
Disposable Insulin Pen Comprehensive Study by Type (Prefilled Pens, Disposable Cartridge-Based Pens), Application (Daily Insulin Injections, Basal-Bolus Therapy), Components (Cartridge, Dial, Needle)...
$ 3450
Tumor Ablation Devices Comprehensive Study by Type (Thermal (Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation), Non-Thermal (Cryoablation, Hydromechanica...
$ 3650
Neonatal Thermoregulation Devices Comprehensive Study by Type (Neonatal Incubators, Neonatal Cooling Systems, Warmers), Application (Hospitals, Nursing Homes, Pediatric and Neonatal Clinics, Others),...
$ 3350